Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dynamic Pharmaceuticals Invesco ETF (PJP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 443,187,000
  • Market Capitalization, $K 443,187
  • Shares Outstanding, K 6,900
  • 60-Month Beta 1.15
  • Price/Book 3.91
  • Price/Earnings ttm 15.53
  • Annual Dividend & Yield 0.70 (1.09%)
  • Most Recent Dividend 0.061 on 03/18/19
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.72 +0.47%
on 03/25/19
69.38 -7.73%
on 03/04/19
-2.53 (-3.80%)
since 02/25/19
3-Month
58.40 +9.62%
on 12/26/18
69.38 -7.73%
on 03/04/19
+5.73 (+9.83%)
since 12/24/18
52-Week
58.29 +9.83%
on 12/24/18
74.29 -13.82%
on 08/29/18
+2.72 (+4.44%)
since 03/23/18

Most Recent Stories

More News
4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run

These sector ETFs emerged winners in the 10-year old bull market.

FDN : 138.06 (+0.07%)
XLY : 112.33 (+0.59%)
VCR : 169.72 (+0.55%)
PJP : 64.02 (-0.26%)
FXH : 75.87 (-0.29%)
QTEC : 81.62 (-0.69%)
FBT : 145.95 (+0.20%)
SPY : 279.04 (-0.08%)
XBI : 87.99 (+0.15%)
4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run

These sector ETFs emerged winners in the 10-year old bull market.

FDN : 138.06 (+0.07%)
XLY : 112.33 (+0.59%)
VCR : 169.72 (+0.55%)
PJP : 64.02 (-0.26%)
FXH : 75.87 (-0.29%)
QTEC : 81.62 (-0.69%)
FBT : 145.95 (+0.20%)
SPY : 279.04 (-0.08%)
XBI : 87.99 (+0.15%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

TGTX : 7.04 (+3.07%)
RKDA : 6.95 (-3.47%)
XPH : 40.90 (-0.73%)
HZNP : 26.87 (+0.11%)
IHE : 151.82 (-0.43%)
PJP : 64.02 (-0.26%)
FTXH : 21.79 (-0.23%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

TGTX : 7.04 (+3.07%)
RKDA : 6.95 (-3.47%)
XPH : 40.90 (-0.73%)
HZNP : 26.87 (+0.11%)
IHE : 151.82 (-0.43%)
PJP : 64.02 (-0.26%)
FTXH : 21.79 (-0.23%)
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

XPH : 40.90 (-0.73%)
IHE : 151.82 (-0.43%)
PJP : 64.02 (-0.26%)
PPH : 60.16 (-0.59%)
FTXH : 21.79 (-0.23%)
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

XPH : 40.90 (-0.73%)
IHE : 151.82 (-0.43%)
PJP : 64.02 (-0.26%)
PPH : 60.16 (-0.59%)
FTXH : 21.79 (-0.23%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

NVO : 51.56 (+1.66%)
PJP : 64.02 (-0.26%)
IHE : 151.82 (-0.43%)
LLY : 129.87 (+1.22%)
PPH : 60.16 (-0.59%)
GSK : 41.21 (-0.10%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

AZN : 42.55 (-0.09%)
MRK : 82.35 (+0.07%)
PJP : 64.02 (-0.26%)
IHE : 151.82 (-0.43%)
PPH : 60.16 (-0.59%)
PFE : 41.89 (+0.10%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 87.92 (-0.26%)
BLUE : 146.22 (-0.29%)
IHE : 151.82 (-0.43%)
PJP : 64.02 (-0.26%)
IBB : 108.32 (+0.14%)
BBH : 125.50 (+0.06%)
IEIH : 25.47 (unch)
BMY : 47.49 (-1.39%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 87.92 (-0.26%)
BLUE : 146.22 (-0.29%)
IHE : 151.82 (-0.43%)
PJP : 64.02 (-0.26%)
IBB : 108.32 (+0.14%)
BBH : 125.50 (+0.06%)
IEIH : 25.47 (unch)
BMY : 47.49 (-1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade PJP with:

Fund Summary

The Invesco Dynamic Pharmaceuticals ETF is based on the Dynamic Pharmaceutical Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies...

See More

Key Turning Points

2nd Resistance Point 64.80
1st Resistance Point 64.41
Last Price 64.02
1st Support Level 63.68
2nd Support Level 63.33

See More

52-Week High 74.29
Fibonacci 61.8% 68.18
Fibonacci 50% 66.29
Fibonacci 38.2% 64.40
Last Price 64.02
52-Week Low 58.29

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar